← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-11 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
ADCBiologicstaleTakedaPhase 2

TAK-188 (TAK-188)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleTakedaPhase 2

TAK-853 (TAK-853)

Ovarian Cancer; Solid Tumors · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 44%임상시험 1상태 RECRUITING
AntibodystalePresage BiosciencesPhase 1

TAK-981 + Avelumab (TAK-981 + Avelumab)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystalePresage BiosciencesPhase 1

TAK-981 + Cetuximab (TAK-981 + Cetuximab)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

TAS-102+bevacizumab+local treatment (TAS-102+bevacizumab+local treatment)

Metastatic Colorectal Cancer (CRC) · Metastatic Colorectal Cancer (CRC)

#MetastaticColorectalCancerCRC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

TAS-102, oxaliplatin, irinotecan with bevacizumab (TAS-102, oxaliplatin, irinotecan with bevacizumab)

Colon Cancer; Rectal Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleMariella EnocPhase 2

TCR alfa beta T cell depletion (TCR alfa beta T cell depletion)

Acute Lymphoblastic Leukemia; Leukemia Acute Myeloid - AML · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleWashington University School of…Phase 2

TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft (TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft)

AML, Childhood; Aml · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

TCR reserved and Power3 (SPPL3, TCR reserved and Power3, TCR reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T cell)

Acute Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

TCR reserved and Power3 (SPPL3, TCR reserved and Power3, TCR reserved and Power3 (SPPL3) gene knock-out allogeneic CD19-targeting CAR-T cell (ATHENA-2 CAR-T))

Non-hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleSun Yat-Sen Memorial Hospital o…Phase 1

TCR-T therapy (TCR-T therapy)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 4%임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

TCR1020-CD8 T cells (TCR1020-CD8 T cells)

Metastatic Pancreatic Adenocarcinoma; Colorectal Cancer · Metastatic Pancreatic Adenocarcinoma

#MetastaticPancreaticAdenocarcino#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

TCR1188-ABC cells (TCR1188-ABC cells)

Cholangiocarcinoma; Colorectal Cancer · Cholangiocarcinoma

#Cholangiocarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleAthenex, Inc.Phase 1

TCRT-ESO-A2 (TCRT-ESO-A2)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleUniversity of Wisconsin, MadisonPhase 1

TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC, TCRαβ+/CD19+ depleted Hematopoietic stem cell, TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft)

Blood Disease · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleT.O.A.D. Oncology SAPhase 2

TD001 (TD001)

Metastatic Castration-Resistant Prostatic Cancer · Metastatic Castration-Resistant Prostati

#MetastaticCastration-ResistantPr#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleAsan Medical CenterApproved

TDM-based infliximab intravenous therapy (TDM-based infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 1

TGFBR-2 KO CD70 CAR NK (TGFBR-2 KO CD70 CAR NK)

Clear Cell Carcinoma; Phase 1 · Clear Cell Carcinoma

#ClearCellCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 1

TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells (TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells)

Breast Cancer · TROP2

#TROP2#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 1

TGFβR-KO CAR-EGFR T Cells (TGFβR-KO CAR-EGFR T Cells)

Solid Tumor, Adult; EGFR Overexpression · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE

154 / 177 페이지

← 이전다음 →